Elhízás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• GLP-1 172
• PPAR 0
• FTO 0
• AMPK 3
• GIP 20
• SGLT2 5
• STAT3 0
• SIRT1 0
• PI3K 0
• NRF2 0
• AKT 0
• mTOR 2
• NLRP3 3
• MAPK 0
• TP53 0
• TNF 0
• IL-6 1
• TLR4 0
• BDNF 2
• DPP-4 1
• JNK 0
• APOE 0
• ERK 0
• IL-17 1
• PTEN 0
• STING 0
• ACE2 0
• HIF-1 0
• PCSK9 0
• VEGF 0
• IL-1 0
• JAK 0
• PNPLA3 2
• YAP 0
• HMGB1 0
• CTNNB1 0
• HER2 0
• MMP-9 0
• PD-L1 0
• PINK1 0
• TFEB 0
• TREM2 0
• CCR5 0
• FGFR 0
• GPX4 0
• IGF1R 0
• IL-23 0
• METTL3 0
• PD-1 0
• STK11 0
• AR 0
• BCL-2 0
• CFTR 0
• COX-2 0
• HDAC 0
• EGFR 0
• HSP90 0
• MEK 0
• MYC 0
• PKM2 0

8751 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAID · F30

  The role of Aiolos in lung-resident CD8+ memory T cell programming.

  Ohio State University· Columbus, Egyesült Államok· 45 821 USD awarded in fiscal year 2026· until 2030. okt.

• NIH NICHD · F32

  Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth

  University of Minnesota· Minneapolis, Egyesült Államok· 76 300 USD awarded in fiscal year 2026· until 2029. jún.

• NIH NIAID · F31

  Dysregulation of Aging Regulatory T-Cell Response in Autoimmune Disease

  Utah State Higher Education System--University of Utah· Salt Lake City, Egyesült Államok· 38 914 USD awarded in fiscal year 2026· until 2029. okt.

• NIH NIA · R01

  The effects of sleep and diet on glial function

  Texas A&m University· College Station, Egyesült Államok· 527 686 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIDDK · RC2

  Interorgan Genomic Atlas for Discovery of Bioenergetic Dynamics and Mechanisms of Time-Restricted Feeding

  Northwestern University· Chicago, Egyesült Államok· 1 641 136 USD awarded in fiscal year 2026· until 2031. jún.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Elucidating the role of maternal nutrient stores in the metabolism of the preimplantation embryo (MaterMeta)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Studying the role of Tbx-3 expressing neurons during obesity and ageing (OBrAgeing)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 226 421 EUR· until 2029. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  Selective Sensory Vagal Interface: a bionic platform for internal organ modulation (VisceraLink)

  Medizinische Universitaet Wien· Wien, Ausztria· EU contribution 2 210 625 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Metabolic disease heterogeneity definition, prevention and remission with targeted interventions (MEDIculous REMeDy)

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 4 437 236 EUR· until 2030. dec.· 11 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Bridging Chronobiology and Physiology through Expert Training (ChronoBridge)

  Ecole Polytechnique Federale de Lausanne· Lausanne, Svájc· EU contribution 3 885 022 EUR· until 2030. dec.· 9 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 4093 running projects, newest first. Listed amounts together: 2,5 Mrd USD + 430,1 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  Physical Exercise Prehabilitation Program in mEtabolic suRgery

  NCT06889207· Flevoziekenhuis· Frissítve: 2026. nov. 12.

  “Higher dropout rate (38% versus the 10% on which the original sample size was based). Interim analysis revealed that the effect on the primary outcome measure was already highly statistically significant.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

  NCT01105858· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Frissítve: 2026. nov. 12.

  “Recruitment temporarily paused.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Small Bowel Diversion

  NCT06374368· University of Ostrava· Frissítve: 2026. nov. 6.

  “Halted for safety concerns after jejuno-colic diversion: frequent and serious late complications, incl. hepatic fibrosis, lean body mass loss and surgical reversal of the anastomosis.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Probiotics and Insulin Resistance in Obese Asthmatics

  NCT05949255· University of Alabama at Birmingham· Frissítve: 2026. nov. 5.

  “Lost coordinator and statistician before no cost extension study could be completed.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity

  NCT07423065· University of Primorska· Frissítve: 2026. nov. 4.

  “The study has been temporarily suspended pending approval from the Slovenian Agency for Medicinal Products and Medical Devices (JAZMP). The need for this additional regulatory approval was identified following communication with JAZMP.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

  NCT07677865· West China Hospital· Frissítve: 2026. okt. 16.

  “poor accrual and funding issues”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

  NCT07553299· Verdiva Bio Dev Limited· Frissítve: 2026. okt. 13.

  “The Study Sponsor made a business decision not to continue the study. The decision was not based on safety findings.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

  NCT05532020· Soleno Therapeutics, Inc.· Frissítve: 2026. okt. 13.

  “Company Decision”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Weight Management Program for Obese Preschool Children

  NCT07126210· Peking University· Frissítve: 2026. szept. 16.

  “Study terminated prematurely due to poor accrual. The actual number of eligible children recruited from kindergartens was far lower than expected, making the study unfeasible.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  A Food Security Intervention for the Prevention of Cancer in Low-income Families

  NCT07039630· Roswell Park Cancer Institute· Frissítve: 2026. szept. 15.

  “behavioral intervention is being prepared”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Use of a Mandibular Advancement Appliance in Children With Obstructive Sleep Apnea

  NCT07902908· National Institute of Dental and Craniofacial Research (NIDCR)· Forrás

• School- and Family-Based Lifestyle Programme for Primary School Children in Punjab, Pakistan: A Feasibility Study

  NCT07932028· Central South University· Forrás

• Aerobic Exercise Added to Diaphragmatic Breathing for Nocturnal Enuresis in Overweight and Obese Children

  NCT07930351· Hungarian University of Sports Science· Forrás

• A Study to Evaluate ALN-2232 in Participants With Obesity

  NCT07463846· Alnylam Pharmaceuticals· Forrás

• E-Bike Commuting and Health in Overweight College Students

  NCT07114991· University of Wisconsin, River Falls· Forrás

• A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

  NCT06028113· Children's Hospital Medical Center, Cincinnati· Forrás

• Family Grocery Study R01

  NCT07806721· State University of New York at Buffalo· Forrás

• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· Amgen Inc.· Forrás

• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Eli Lilly and Company· Forrás

• HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking

  NCT06952348· Karolinska Institutet· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 21
• Organoids 10
• Mendelian Randomization Analysis 180
• CRISPR-Cas Systems 7
• Gene Expression Profiling 144
• Sequence Analysis, RNA 10
• Whole Genome Sequencing 4
• Exome Sequencing 19
• Proteomics 127
• Metabolomics 191
• Mass Spectrometry 28
• Flow Cytometry 16
• Immunohistochemistry 41
• Xenograft Model Antitumor Assays 15
• Positron-Emission Tomography 26
• Magnetic Resonance Imaging 258
• Machine Learning 155
• Deep Learning 20
• Cohort Studies 1014
• Genome-Wide Association Study 203

• Individual differences in eating attitudes are associated with distinct resting-state functional connectivity patterns in healthy adults.

  Brain Imaging Behav, 2026. nov.

• Quantifying Pancreatic Fat Using a Free-Breathing Acquisition in Adults With Obesity Undergoing Diet-Induced Weight Loss-Results From the LION Study.

  NMR Biomed, 2026. nov.

• From imaging to insight: Assessing the diagnostic performance of MRI in endometrial cancer staging.

  J Cancer Res Ther, 2026. okt.

• Comparison of Data-Driven Phenotyping Systems for Metabolic Dysfunction-Associated Steatotic Liver Disease: Implications for Treatment Response.

  J Obes Metab Syndr, 2026. okt.

• Patients with MASH experience worse health-related quality of life: a multinational real-world study using LiverMultiScan.

  Qual Life Res, 2026. okt.

• [Patients with papillary craniopharyngioma successfully treated with BRAF and MEK inhibitors].

  Lakartidningen, 2026. okt.

• Effects of time-restricted eating and supervised exercise on intrahepatic fat and cardiometabolic health in adults with obesity: the TEMPUS randomized controlled trial.

  Nat Commun, 2026. okt.

• Regional Adipose Distribution Reveals Differential Genetic Risk Patterns for Cardiometabolic Diseases.

  J Am Heart Assoc, 2026. okt.

• The Effect of a Very Low-Carbohydrate Diet on Intermuscular Adipose Tissue and Muscle Function in Older Adults With Obesity.

  Obesity (Silver Spring), 2026. okt.

• Surveillance for Hepatocellular Carcinoma in Patients at High Risk.

  Radiographics, 2026. okt.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.